Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
26.72
-0.44 (-1.62%)
Feb 13, 2026, 4:00 PM EST - Market closed
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.59 billion as of February 13, 2026. Its market cap has increased by 52.59% in one year.
Market Cap
1.59B
Enterprise Value
1.11B
1-Year Change
52.59%
Ranking
Category
Stock Price
$26.72
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.59B, an increase of 62.81%. That is a compound annual growth rate of 17.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.59B | 73.51% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.71B |
| Tango Therapeutics | 1.70B |
| Innoviva | 1.68B |
| Immunocore Holdings | 1.67B |
| Nurix Therapeutics | 1.66B |
| Corvus Pharmaceuticals | 1.65B |
| Oculis Holding AG | 1.65B |
| MBX Biosciences | 1.65B |